Search

Board elections

All members* who have paid their annual fees, have the privilege to influence the composition of the EHA Board. We need your involvement in the selection of EHA’s governmental body.

Read more

Access

Improving affordable and equal access to innovative therapies in hematology for patients across Europe is EHA’s overriding advocacy priority.

Read more

Pivotal Ruxolitinib Data Shows Promise for Patients with PV.

 

Polycythemia vera (PV) is a chronic, incurable blood cancer with limited treatment options. If uncontrolled, PV can cause serious cardiovascular complications, such as stroke and heart attack.

Read more

Virtual: EHA-PTHiT Hematology Mini Tutorial - a report

VIRTUAL: EHA-PTHiT Hematology Mini Tutorial

April 12 -13, 2021

Meeting Chairs:

Prof G Gaidano (European Hematology Association)
Prof I Hus (Polish Society of Hematology and Transfusion)
Prof T Robak (Polish Society of Hematology and Transfusion)
As a prelude to the full Tutorial planned for later this…

Read more

Travel Grants

Travel grant application is now open Apply here

Travel grants are intended to support young investigators to participate in the 7th European CAR T-cell Meeting; therefore, applicants should be 40 years of age or younger.

Read more

European Hematology Exam

The 3rd European Hematology Exam will take place during the 24th EHA Congress in Amsterdam, The Netherlands.

Read more